Skip to main content
H.R. 2706 117th Congress House

Freedom from Price Gouging Act

Official title: To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.

Introduced: April 20, 2021 See on congress.gov
Health Civil actions and liabilityCongressional oversightGovernment studies and investigationsHealth care costs and insurance
More subjectsShow fewer subjects
Inflation and pricesMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 2021
Referred to the Subcommittee on Health.
Apr 20, 2021
Referred to the Subcommittee on Social Security.
Apr 20, 2021
Referred to the Subcommittee on Health.
Apr 20, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 20, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 21, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Freedom from Price Gouging Act

This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.

 Related & companion bills 4
  • HR 3 Elijah E. Cummings Lower Drug Costs Now Act
  • HR 5376 An act to provide for reconciliation pursuant to title II of S. Con. Res. 14.
  • HR 5260 Reduced Costs and Continued Cures Act
  • HR 5237 Reduced Costs and Continued Cures Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 3
All 3 Democratic 2
Jones, Mondaire
· Jun 14, 2022
 D
Crow, Jason
Colorado · Apr 20, 2021
 D
Underwood, Lauren
Illinois · Apr 20, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2706: Freedom from Price Gouging Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2706/
MLA
"H.R. 2706: Freedom from Price Gouging Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2706/.
Bluebook (legal)
H.R. 2706, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2706/.
Markdown link
[H.R. 2706: Freedom from Price Gouging Act](https://openamerica.io/bill/117-HR-2706/)
Report a problem